The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Study of the Efficacy and Safety of Ulipristal Acetate Intermittent Treatment for Abnormal Uterine Bleeding Associated With Leiomyomas
Official Title: A Randomized, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of Ulipristal Acetate for the Intermittent Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas
Study ID: NCT02147158
Brief Summary: This study will evaluate the superiority of ulipristal acetate versus placebo for the treatment of abnormal uterine bleeding associated with uterine fibroids
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: No
Watson Investigational Site 138, Mesa, Arizona, United States
Watson Investigational Site 147, Phoenix, Arizona, United States
Watson Investigational Site 106, Scottsdale, Arizona, United States
Watson Investigational Site 124, Tucson, Arizona, United States
Watson Investigational Site 155, Little Rock, Arkansas, United States
Watson Investigational Site 155, Encino, California, United States
Watson Investigational Site 157, Hawaiian Gardens, California, United States
Watson Investigational Site 134, La Mesa, California, United States
Watson Investigational Site 127, San Diego, California, United States
Watson Investigational Site 151, San Diego, California, United States
Watson Investigational Site 159, Denver, Colorado, United States
Watson Investigational Site 131, Clearwater, Florida, United States
Watson Investigational Site 135, Miramar, Florida, United States
Watson Investigational Site 132, North Miami, Florida, United States
Watson Investigational Site 161, Orlando, Florida, United States
Watson Investigational Site 123, Plantation, Florida, United States
Watson Investigational Site 112, Sarasota, Florida, United States
Watson Investigational Site 102, Wellington, Florida, United States
Watson Investigational Site 101, West Palm Beach, Florida, United States
Watson Investigational Site 160, Atlanta, Georgia, United States
Watson Investigational Site 103, Sandy Springs, Georgia, United States
Watson Investigational Site 117, Savannah, Georgia, United States
Watson Investigational Site 113, Champaign, Illinois, United States
Watson Investigational Site 119, Schaumburg, Illinois, United States
Watson Investigational Site 162, Brownsburg, Indiana, United States
Watson Investigational Site 104, Granger, Indiana, United States
Watson Investigational Site 150, Covington, Louisiana, United States
Watson Investigational Site 130, Metairie, Louisiana, United States
Watson Investigational Site 116, New Orleans, Louisiana, United States
Watson Investigational Site 108, Las Vegas, Nevada, United States
Watson Investigational Site 107, Las Vegas, Nevada, United States
Watson Investigational Site 111, Lawrenceville, New Jersey, United States
Watson Investigational Site 158, Moorestown, New Jersey, United States
Watson Investigational Site 115, Albuquerque, New Mexico, United States
Watson Investigational Site 155, Bronx, New York, United States
Watson Investigational Site 126, Durham, North Carolina, United States
Watson Investigational Site 128, Greensboro, North Carolina, United States
Watson Investigational Site 145, New Bern, North Carolina, United States
Watson Investigational Site 146, Raleigh, North Carolina, United States
Watson Investigational Site 118, Winston-Salem, North Carolina, United States
Watson Investigational Site 155, Cincinnati, Ohio, United States
Watson Investigational Site 155, Cleveland, Ohio, United States
Watson Investigational Site 148, Cleveland, Ohio, United States
Watson Investigational Site 139, Englewood, Ohio, United States
Watson Investigational Site 133, Philadelphia, Pennsylvania, United States
Watson investigational site 142, Pittsburgh, Pennsylvania, United States
Watson Investigational Site 105, West Reading, Pennsylvania, United States
Watson Investigational Site 136, Bluffton, South Carolina, United States
Watson Investigational Site 110, Charleston, South Carolina, United States
Watson Investigational Site 153, Columbia, South Carolina, United States
Watson Investigational Site 154, Greenville, South Carolina, United States
Watson Investigational Site 155, Knoxville, Tennessee, United States
Watson Investigational Site 122, Dallas, Texas, United States
Watson Investigational Site 114, Frisco, Texas, United States
Watson Investigational Site 109, Houston, Texas, United States
Watson Investigational Site 155, Houston, Texas, United States
Watson Investigational Site 120, San Antonio, Texas, United States
Watson Investigational Site 129, Webster, Texas, United States
Watson Investigational Site 152, Norfolk, Virginia, United States
Watson Investigational Site 137, Virginia Beach, Virginia, United States
Watson Investigational Site 121, Seattle, Washington, United States
Watson Investigational Site 140, Hamilton, Ontario, Canada
Watson Investigational Site 144, Ottawa, Ontario, Canada
Name: Anna Chan
Affiliation: Allergan
Role: STUDY_DIRECTOR